Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer.
Journal: The New England journal of medicine
Published: May 27, 2026
HERIZON-GEA-01: Zanidatamab + chemo ± tislelizumab for 1L treatment of HER2-positive gastroesophageal adenocarcinoma.
Journal: Future oncology (London, England)
Published: August 24, 2022
Mantle cell lymphoma relapsed after autologous stem cell transplantation: a single-center experience.
Journal: Blood research
Published: November 19, 2019
Pan-cancer transcriptional signatures predictive of oncogenic mutations reveal that Fbw7 regulates cancer cell oxidative metabolism.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 08, 2018
Cutaneous phaeohyphomycosis in a hematopoietic stem cell transplant patient caused by Alternaria rosae: First case report.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: March 21, 2016
Targeted therapy in gastroesophageal cancers: past, present and future.
Journal: Gastroenterology report
Published: September 07, 2015
A (heat) shocking development: FBXW7 loss unleashes HSF1 to drive melanoma invasion and metastasis.
Journal: Pigment cell & melanoma research
Published: July 17, 2015
Fbw7 dimerization determines the specificity and robustness of substrate degradation.
Journal: Genes & development
Published: December 04, 2013
Fbxw7 hotspot mutations and human colon cancer: mechanistic insights from new mouse models.
Journal: Gut
Published: September 04, 2013
Fbw7 and p53 cooperatively suppress advanced and chromosomally unstable intestinal cancer.
Journal: Molecular and cellular biology
Published: April 05, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026